Pharming Group N.V. (PHAR)
USD 8.96
(2.4%)
USD 8.96
(2.4%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 171.54 Million USD | 2.91% |
| 2022 | 166.69 Million USD | 3.16% |
| 2021 | 161.59 Million EUR | -0.38% |
| 2020 | 162.21 Million EUR | 179.03% |
| 2019 | 58.13 Million EUR | -30.31% |
| 2018 | 83.42 Million EUR | -14.47% |
| 2017 | 97.53 Million EUR | 37.61% |
| 2016 | 70.87 Million EUR | 308.63% |
| 2015 | 17.34 Million EUR | 796.55% |
| 2014 | 1.93 Million EUR | -28.99% |
| 2013 | 2.72 Million EUR | -27.87% |
| 2012 | 3.77 Million EUR | -15.11% |
| 2011 | 4.44 Million EUR | 0.0% |
| 2010 | - EUR | -100.0% |
| 2009 | 41.96 Million EUR | -20.18% |
| 2008 | 52.57 Million EUR | 129.4% |
| 2007 | 22.91 Million EUR | 999.75% |
| 2006 | 2.08 Million EUR | 830.96% |
| 2005 | 223.85 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 133.11 Million USD | -20.39% |
| 2024 Q3 | 95.41 Million USD | -4.53% |
| 2024 Q1 | 167.2 Million USD | -2.53% |
| 2023 Q3 | 163.98 Million USD | -3.61% |
| 2023 Q4 | 171.54 Million USD | 4.61% |
| 2023 FY | 171.54 Million USD | 2.91% |
| 2023 Q1 | 170.39 Million USD | 2.22% |
| 2023 Q2 | 170.13 Million USD | -0.16% |
| 2022 Q1 | 157.78 Million USD | 10.56% |
| 2022 Q2 | 149 Million USD | -5.57% |
| 2022 Q3 | 139.18 Million USD | -6.59% |
| 2022 Q4 | 166.69 Million USD | 19.77% |
| 2022 FY | 166.69 Million USD | 3.16% |
| 2021 Q1 | 153.6 Million EUR | -5.31% |
| 2021 FY | 161.59 Million EUR | -0.38% |
| 2021 Q4 | 142.72 Million EUR | -13.39% |
| 2021 Q3 | 164.78 Million EUR | -3.33% |
| 2021 Q2 | 170.46 Million EUR | 10.97% |
| 2020 Q1 | 140.36 Million EUR | 141.44% |
| 2020 Q4 | 162.21 Million EUR | 6.25% |
| 2020 Q3 | 152.67 Million EUR | 5.31% |
| 2020 FY | 162.21 Million EUR | 179.03% |
| 2020 Q2 | 144.97 Million EUR | 3.29% |
| 2019 Q3 | 66.24 Million EUR | -11.21% |
| 2019 Q4 | 58.13 Million EUR | -12.24% |
| 2019 Q2 | 74.6 Million EUR | -7.04% |
| 2019 FY | 58.13 Million EUR | -30.31% |
| 2019 Q1 | 80.25 Million EUR | -3.8% |
| 2018 FY | 83.42 Million EUR | -14.47% |
| 2018 Q4 | 83.42 Million EUR | -7.73% |
| 2018 Q3 | 90.4 Million EUR | -6.4% |
| 2018 Q2 | 96.59 Million EUR | -0.31% |
| 2018 Q1 | 96.89 Million EUR | -0.65% |
| 2017 Q3 | 103.84 Million EUR | 0.32% |
| 2017 Q4 | 97.53 Million EUR | -6.08% |
| 2017 Q2 | 103.51 Million EUR | 47.69% |
| 2017 Q1 | 70.09 Million EUR | -1.11% |
| 2017 FY | 97.53 Million EUR | 37.61% |
| 2016 Q2 | 17.69 Million EUR | 1.33% |
| 2016 FY | 70.87 Million EUR | 308.63% |
| 2016 Q4 | 70.87 Million EUR | 313.79% |
| 2016 Q3 | 17.12 Million EUR | -3.22% |
| 2016 Q1 | 17.46 Million EUR | 0.7% |
| 2015 FY | 17.34 Million EUR | 796.55% |
| 2015 Q3 | 18.37 Million EUR | 1381.41% |
| 2015 Q4 | 17.34 Million EUR | -5.61% |
| 2015 Q1 | 1.31 Million EUR | -31.88% |
| 2015 Q2 | 1.24 Million EUR | -5.87% |
| 2014 FY | 1.93 Million EUR | -28.99% |
| 2014 Q4 | 1.93 Million EUR | -0.87% |
| 2014 Q3 | 1.95 Million EUR | -13.93% |
| 2014 Q2 | 2.26 Million EUR | 1.46% |
| 2014 Q1 | 2.23 Million EUR | -17.97% |
| 2013 Q3 | 6.51 Million EUR | -44.54% |
| 2013 FY | 2.72 Million EUR | -27.87% |
| 2013 Q1 | 15.8 Million EUR | 318.35% |
| 2013 Q2 | 11.74 Million EUR | -25.67% |
| 2013 Q4 | 2.72 Million EUR | -58.17% |
| 2012 Q1 | 8.23 Million EUR | 85.07% |
| 2012 Q4 | 3.77 Million EUR | -4.06% |
| 2012 Q3 | 3.93 Million EUR | 0.0% |
| 2012 FY | 3.77 Million EUR | -15.11% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | 4.44 Million EUR | 0.0% |
| 2011 FY | 4.44 Million EUR | 0.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2010 FY | - EUR | -100.0% |
| 2010 Q2 | 42.09 Million EUR | -13.55% |
| 2010 Q1 | 48.68 Million EUR | 16.03% |
| 2010 Q3 | 15.14 Million EUR | -64.01% |
| 2010 Q4 | 102.4 Thousand EUR | -99.32% |
| 2009 FY | 41.96 Million EUR | -20.18% |
| 2009 Q4 | 41.96 Million EUR | 0.0% |
| 2008 FY | 52.57 Million EUR | 129.4% |
| 2007 FY | 22.91 Million EUR | 999.75% |
| 2006 FY | 2.08 Million EUR | 830.96% |
| 2005 FY | 223.85 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -120706.338% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2140.252% |
| XOMA Corporation | 124.45 Million USD | -37.843% |
| Mesoblast Limited | 118.92 Million USD | -44.249% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 25.152% |
| Aptorum Group Limited | 3.36 Million USD | -5001.866% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -13103.732% |
| HilleVax, Inc. | 51.19 Million USD | -235.095% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -585.029% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -721.409% |
| Precision BioSciences, Inc. | 31.26 Million USD | -448.628% |
| Dyadic International, Inc. | 136.92 Thousand USD | -125180.255% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -108472.785% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -5873.015% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3044.73% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -80061.215% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3036.679% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 25.231% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1280.755% |
| IGM Biosciences, Inc. | 40.5 Million USD | -323.505% |
| Opthea Limited | 200.62 Million USD | 14.496% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -231.328% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3076.759% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1648.14% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -2682.563% |
| NextCure, Inc. | 6.6 Million USD | -2497.199% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -27479.449% |
| Ovid Therapeutics Inc. | 46 Million USD | -272.91% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -707.689% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -467.729% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -176.351% |
| Senti Biosciences, Inc. | 37.66 Million USD | -355.437% |
| Apollomics, Inc. | 4.66 Million USD | -3580.433% |
| PureTech Health plc | 25.51 Million USD | -572.409% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -53844.969% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1222.018% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -102.595% |
| ChromaDex Corporation | 3.27 Million USD | -5134.818% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -64.659% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -350.202% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -63.727% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -65.686% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -69.203% |
| Fortress Biotech, Inc. | 88.59 Million USD | -93.635% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -171.574% |
| Celcuity Inc. | 37.44 Million USD | -358.11% |
| ContextLogic Inc. | 6 Million USD | -2759.083% |
| GH Research PLC | 343 Thousand USD | -49913.12% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2515.414% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -463535.135% |
| ImmuCell Corporation | 11.96 Million USD | -1333.208% |
| Amarin Corporation plc | 8.73 Million USD | -1863.431% |
| TG Therapeutics, Inc. | 110.79 Million USD | -54.831% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -194.341% |
| Acelyrin, Inc. | 1.19 Million USD | -14267.253% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -507.046% |
| Novavax, Inc. | 280.63 Million USD | 38.873% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -23.387% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 97.041% |
| AnaptysBio, Inc. | 17.81 Million USD | -862.979% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3078.525% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1191.171% |
| AbCellera Biologics Inc. | 77.38 Million USD | -121.692% |
| CorMedix Inc. | 667.63 Thousand USD | -25594.544% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1465.906% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 93.653% |
| Aptose Biosciences Inc. | 1 Million USD | -16887.916% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1981704.529% |
| Soligenix, Inc. | 3.49 Million USD | -4808.914% |
| Century Therapeutics, Inc. | 48.17 Million USD | -256.117% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -48.948% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -37972.801% |
| Kura Oncology, Inc. | 17.2 Million USD | -897.355% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2383.999% |
| Ardelyx, Inc. | 55.98 Million USD | -206.429% |
| Ainos, Inc. | 5.96 Million USD | -2776.556% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -85.588% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -7878.837% |
| Prothena Corporation plc | 11.83 Million USD | -1349.472% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1127.601% |
| Autolus Therapeutics plc | 52.96 Million USD | -223.871% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -579.79% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -309.973% |
| Celularity Inc. | 65.41 Million USD | -162.233% |
| Rallybio Corporation | 392 Thousand USD | -43661.48% |
| GRI Bio, Inc. | 14 Thousand USD | -1225221.429% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 49.289% |
| INmune Bio, Inc. | 10.43 Million USD | -1543.624% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 4.5% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2804.068% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -209920.813% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -20646.961% |
| Humacyte, Inc. | 58.1 Million USD | -195.228% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -196.421% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 64.324% |
| Immunocore Holdings plc | 84.03 Million USD | -104.142% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -9157.69% |
| Verastem, Inc. | 41.55 Million USD | -312.794% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1408.486% |
| Histogen Inc. | 4.62 Million USD | -3611.489% |
| Surrozen, Inc. | 3.37 Million USD | -4976.798% |
| Blueprint Medicines Corporation | 774.12 Million USD | 77.84% |
| Organovo Holdings, Inc. | 1.39 Million USD | -12205.954% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -6778.308% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -295667.241% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -102.801% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -81971.094% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -3318.593% |
| Summit Therapeutics Inc. | 106.09 Million USD | -61.684% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -55.444% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -105585.172% |
| Turnstone Biologics Corp. | 3.21 Million USD | -5237.43% |
| Pulmatrix, Inc. | 8.75 Million USD | -1859.171% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -69351.417% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -75.751% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1138.592% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -48.722% |
| Cytokinetics, Incorporated | 755.77 Million USD | 77.302% |
| Exelixis, Inc. | 189.94 Million USD | 9.687% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -460.348% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -54.645% |
| Evogene Ltd. | 1.13 Million USD | -14974.253% |
| Replimune Group, Inc. | 75.86 Million USD | -126.107% |
| PDS Biotechnology Corporation | 23.85 Million USD | -619.217% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -310867.099% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6057.394% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -213455.672% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -350923.123% |
| BioLineRx Ltd. | 11.59 Million USD | -1379.984% |
| Avid Bioservices, Inc. | 207.83 Million USD | 17.461% |
| Insmed Incorporated | 1.2 Billion USD | 85.752% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -7991.745% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -274.773% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -263815.385% |
| MediWound Ltd. | 6.71 Million USD | -2456.176% |
| MiMedx Group, Inc. | 48.09 Million USD | -256.65% |
| OmniAb, Inc. | 25.56 Million USD | -571.12% |
| Alector, Inc. | 38.91 Million USD | -340.786% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 19.815% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 58.666% |
| Mereo BioPharma Group plc | 5.95 Million USD | -2782.14% |
| Zai Lab Limited | 15.15 Million USD | -1032.235% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 64.144% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -10392.049% |
| Aura Biosciences, Inc. | 19.55 Million USD | -777.154% |
| Immunic, Inc. | 1.33 Million USD | -12759.445% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -525.734% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -440.606% |
| Veracyte, Inc. | 12.63 Million USD | -1258.234% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 73.398% |
| FibroGen, Inc. | 170.45 Million USD | -0.639% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1789.054% |
| Allakos Inc. | 41.46 Million USD | -313.71% |
| scPharmaceuticals Inc. | 40.26 Million USD | -325.998% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1485.297% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -113505.96% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -10400.102% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -84027.389% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -3948.737% |
| Precigen, Inc. | 7.09 Million USD | -2317.148% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 89.777% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2244.472% |
| Incyte Corporation | 38.28 Million USD | -348.05% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -56945.897% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -297.398% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1440.178% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6057.394% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 28.113% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -558.699% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -49053.295% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -538.165% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -280.594% |
| Agenus Inc. | 350.24 Million USD | 51.022% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -160385.916% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -11989.147% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -279.222% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -297.38% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -255.688% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -104521.662% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 79.788% |
| UroGen Pharma Ltd. | 100.21 Million USD | -71.179% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -16597.035% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 6.131% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1208474.045% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -56144.262% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -43661.256% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2409.802% |
| Chimerix, Inc. | 2.14 Million USD | -7901.166% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -17530.524% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -382.474% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -99246.742% |
| Pluri Inc. | 29.61 Million USD | -479.309% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1067.37% |
| MeiraGTx Holdings plc | 89.26 Million USD | -92.177% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -803389.461% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -3417.429% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -177.5% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -64.795% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2380.049% |
| NLS Pharmaceutics AG | 1.63 Million USD | -10400.102% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -443.759% |
| Nutriband Inc. | 241.28 Thousand USD | -70996.421% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3037.827% |
| Vor Biopharma Inc. | 35.66 Million USD | -381.057% |
| Roivant Sciences Ltd. | 499.74 Million USD | 65.674% |
| ProKidney Corp. | 4.41 Million USD | -3787.265% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -13892.251% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3125.655% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 90.14% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -30261.947% |
| Bicycle Therapeutics plc | 44.95 Million USD | -281.584% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -340.763% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -138.897% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -95.062% |
| Atai Life Sciences N.V. | 16.47 Million USD | -941.181% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -6898.991% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -25314.074% |
| MediciNova, Inc. | 215.92 Thousand USD | -79346.199% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -6775.551% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -13503.584% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -14934.619% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 7.956% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1566.132% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -207.104% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -4678.412% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1772.558% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1069.28% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1299.453% |
| bluebird bio, Inc. | 330.32 Million USD | 48.068% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1271.702% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -10458.474% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 84.871% |
| BioAtla, Inc. | 2.46 Million USD | -6873.374% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -80.344% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -2993.13% |
| DBV Technologies S.A. | 14.38 Million USD | -1092.859% |
| Fortress Biotech, Inc. | 88.59 Million USD | -93.635% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1641.22% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -806.063% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1036.436% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -715.018% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -52441.708% |
| Galecto, Inc. | 249 Thousand USD | -68793.574% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -10413.107% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 88.558% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -61.737% |
| Entera Bio Ltd. | 390 Thousand USD | -43885.897% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 57.621% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -2663.289% |
| Xencor, Inc. | 83.43 Million USD | -105.606% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -10068.643% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -3621.957% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -13912.527% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1724.171% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -104521.662% |
| Portage Biotech Inc. | 47 Thousand USD | -364889.362% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -13503.584% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -6997.435% |
| OncoCyte Corporation | 2.86 Million USD | -5879.261% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -113842.506% |
| Purple Biotech Ltd. | 351 Thousand USD | -48773.219% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -5330.358% |
| Onconetix, Inc. | 9.88 Million USD | -1635.272% |
| MacroGenics, Inc. | 33.97 Million USD | -404.975% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -8333.878% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3179.392% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1158.307% |
| Aditxt, Inc. | 18.21 Million USD | -841.624% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -541.578% |
| Curis, Inc. | 2.79 Million USD | -6039.764% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -7929.445% |
| Adagene Inc. | 22.3 Million USD | -669.023% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -925.312% |
| BeiGene, Ltd. | 930.18 Million USD | 81.558% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 18.367% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -21120.259% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 71.922% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -225617.105% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -6756.315% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -109.158% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 16.692% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -3593.906% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 93.605% |
| ADMA Biologics, Inc. | 141.41 Million USD | -21.304% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -183.176% |
| Clene Inc. | 32.16 Million USD | -433.394% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -6648.426% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -809.908% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -7715.262% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -238.54% |
| Adicet Bio, Inc. | 20.92 Million USD | -719.848% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 11.205% |
| Absci Corporation | 15.95 Million USD | -975.045% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1020.989% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -745.341% |
| Surrozen, Inc. | 3.37 Million USD | -4976.798% |
| Generation Bio Co. | 97.89 Million USD | -75.235% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -52041.337% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -524.14% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -578.097% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -598.985% |
| Invivyd, Inc. | 2.16 Million USD | -7823.557% |
| Cingulate Inc. | 3.13 Million USD | -5371.757% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -220.849% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -4868178.784% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -34147.15% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -2994.804% |
| Jaguar Health, Inc. | 35.86 Million USD | -378.374% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -272193.651% |
| 2seventy bio, Inc. | 256.67 Million USD | 33.166% |
| Clearside Biomedical, Inc. | 43 Million USD | -298.933% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -28348.59% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -199.878% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -2956.67% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -35546.085% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -506.766% |
| Innoviva, Inc. | 449.07 Million USD | 61.8% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -748.435% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -151.422% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -897.529% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -37.743% |
| Evaxion Biotech A/S | 10.86 Million USD | -1478.197% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -105.717% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -129.011% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2540.779% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -418302.439% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -535.587% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -36791.398% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -525.415% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1579.673% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -4722.744% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -10931.833% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -13514.683% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1087.656% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -18834.327% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -231.629% |
| ImmunityBio, Inc. | 883.67 Million USD | 80.587% |
| Korro Bio, Inc. | 33.2 Million USD | -416.593% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -141.694% |
| Kineta, Inc. | 1.31 Million USD | -12925.437% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -73062.566% |
| BioVie Inc. | 6.11 Million USD | -2706.946% |
| Codexis, Inc. | 22.36 Million USD | -667.059% |
| Celularity Inc. | 65.41 Million USD | -162.233% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -44689.817% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -76380.16% |
| Kodiak Sciences Inc. | 181.63 Million USD | 5.554% |
| Cibus, Inc. | 24.62 Million USD | -596.743% |
| Annexon, Inc. | 31.35 Million USD | -447.106% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -7224.722% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 88.198% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -128.617% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -4295.209% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -964.984% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -53.866% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -272.608% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -434.109% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -17315.736% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1397.294% |
| Alkermes plc | 290.73 Million USD | 40.995% |
| Arcellx, Inc. | 97.62 Million USD | -75.718% |
| Moolec Science SA | 2.64 Million USD | -6384.925% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -7882.55% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2617.329% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -547.022% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -5430.142% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -7041.757% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -9798.731% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -195.228% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -502.187% |
| Geron Corporation | 85.89 Million USD | -99.705% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -276.939% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 97.204% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -148740.821% |
| Notable Labs, Ltd. | 2.04 Million USD | -8272.133% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -407.08% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3045.882% |
| IN8bio, Inc. | 4.89 Million USD | -3405.927% |
| 89bio, Inc. | 27.1 Million USD | -532.821% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -42786.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -219.403% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -6710.044% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -12721.001% |
| Liquidia Corporation | 3.5 Million USD | -4797.088% |
| Mustang Bio, Inc. | 2.49 Million USD | -6767.294% |
| Immunovant, Inc. | 138 Thousand USD | -124207.971% |
| Vericel Corporation | 88.14 Million USD | -94.621% |
| Quantum-Si incorporated | 15.3 Million USD | -1020.989% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1867.034% |
| XOMA Corporation | 124.45 Million USD | -37.843% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -62507.664% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -209920.813% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1192.144% |
| Vaxcyte, Inc. | 29.22 Million USD | -487.0% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1473.374% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -84404.926% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -730.284% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -10277.798% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -13514.683% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -42466.998% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -16522.578% |
| PepGen Inc. | 20.1 Million USD | -753.288% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -29785.889% |
| United Therapeutics Corporation | 700 Million USD | 75.494% |
| Solid Biosciences Inc. | 26.26 Million USD | -553.132% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -17315.736% |
| Immuneering Corporation | 4.46 Million USD | -3743.75% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -169746.535% |
| Belite Bio, Inc | 886 Thousand USD | -19261.738% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 28.409% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -704.205% |
| uniQure N.V. | 138.4 Million USD | -23.941% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -919.281% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -100.818% |
| Altimmune, Inc. | 671 Thousand USD | -25465.574% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1192.144% |
| Peak Bio, Inc. | 10.72 Million USD | -1499.964% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1789.054% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -9719.405% |
| Benitec Biopharma Inc. | 284 Thousand USD | -60303.169% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 61.456% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -59126.358% |
| Compugen Ltd. | 1.35 Million USD | -12597.631% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -81398.321% |
| argenx SE | 20 Million USD | -757.725% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -301.125% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -102.88% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -761.126% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -46.378% |
| PolyPid Ltd. | 11.77 Million USD | -1356.363% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -87.567% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4002.966% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -29223.932% |
| Instil Bio, Inc. | 86.05 Million USD | -99.346% |
| Elevation Oncology, Inc. | 30.13 Million USD | -469.217% |
| Immunome, Inc. | 1.65 Million USD | -10296.667% |
| Verona Pharma plc | 51.32 Million USD | -234.207% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1654.398% |
| Shattuck Labs, Inc. | 4.2 Million USD | -3982.461% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -47288.122% |
| Design Therapeutics, Inc. | 3.05 Million USD | -5524.426% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -65375.191% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1105.686% |
| Achilles Therapeutics plc | 4.61 Million USD | -3617.118% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 54.098% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -469.936% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -4539.027% |
| Beam Therapeutics Inc. | 173.17 Million USD | 0.94% |
| Moolec Science SA | 2.64 Million USD | -6384.925% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -36014.737% |
| AEON Biopharma, Inc. | 278 Thousand USD | -61606.835% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2342.269% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -51107.463% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -126.128% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -180.729% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -467.856% |
| Athira Pharma, Inc. | 1.58 Million USD | -10723.028% |
| HCW Biologics Inc. | 6.45 Million USD | -2558.88% |
| XOMA Corporation | 124.45 Million USD | -37.843% |
| NeurAxis, Inc. | 224.26 Thousand USD | -76393.802% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2505.087% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1654.398% |
| 180 Life Sciences Corp. | 1.32 Million USD | -12895.154% |
| Nektar Therapeutics | 230.4 Million USD | 25.545% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -761.126% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -904.355% |
| Arvinas, Inc. | 3.4 Million USD | -4945.441% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -10931.833% |
| Palisade Bio, Inc. | 369 Thousand USD | -46389.16% |
| Nutriband Inc. | 241.28 Thousand USD | -70996.421% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -10413.107% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -20668.16% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -41236.145% |
| Merus N.V. | 12.16 Million USD | -1310.5% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -33.573% |
| Neurogene Inc. | 16.25 Million USD | -955.337% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 44.329% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -501.048% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1141.82% |
| Rezolute, Inc. | 2.22 Million USD | -7599.506% |
| Clene Inc. | 32.16 Million USD | -433.394% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -97896.035% |
| BeyondSpring Inc. | 3.99 Million USD | -4193.992% |
| Synlogic, Inc. | 17.27 Million USD | -893.025% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -13095.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -490028.571% |
| Peak Bio, Inc. | 10.72 Million USD | -1499.964% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -230.383% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2019.41% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 3.091% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2330.849% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -125487.508% |
| MannKind Corporation | 382.37 Million USD | 55.137% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1497.551% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -41842.543% |
| Gossamer Bio, Inc. | 212.46 Million USD | 19.259% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -98489.08% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1772.558% |
| Legend Biotech Corporation | 328.67 Million USD | 47.807% |
| Mural Oncology plc | 15 Million USD | -1042.948% |
| Disc Medicine, Inc. | 2.1 Million USD | -8064.921% |
| Champions Oncology, Inc. | 7.43 Million USD | -2208.816% |
| REGENXBIO Inc. | 89.29 Million USD | -92.121% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -19970.856% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -30921.805% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3068.545% |
| Vaxart, Inc. | 26.51 Million USD | -546.998% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -995.619% |
| Cellectis S.A. | 92.85 Million USD | -84.749% |
| Longeveron Inc. | 2.04 Million USD | -8304.949% |
| Repare Therapeutics Inc. | 3.41 Million USD | -4930.645% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 87.719% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -268.186% |
| Revolution Medicines, Inc. | 87.94 Million USD | -95.062% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -99058.96% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -4239.615% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -54015.142% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -97925.714% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 78.78% |
| Denali Therapeutics Inc. | 52.24 Million USD | -228.372% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1090.833% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -12385.08% |
| Cingulate Inc. | 3.13 Million USD | -5371.757% |
| Passage Bio, Inc. | 26.29 Million USD | -552.411% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2473.818% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -41945.343% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -19088.479% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -734.322% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -6898.635% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -5392.955% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -21052.281% |
| OmniAb, Inc. | 25.56 Million USD | -571.12% |
| Anew Medical, Inc. | 1.6 Million USD | -10588.162% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -479.88% |
| Lipocine Inc. | 17.16 Thousand USD | -999230.071% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1374.008% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -395.394% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2804.068% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -200.045% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -84404.926% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3221.297% |
| Ocugen, Inc. | 6.94 Million USD | -2371.474% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1114.134% |
| Q32 Bio Inc. | 1.31 Million USD | -12915.554% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -25427.53% |
| Alumis Inc. Common Stock | 32.58 Million USD | -426.535% |
| Equillium, Inc. | 824 Thousand USD | -20718.568% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1789.47% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -56928.45% |
| Dominari Holdings Inc. | 3.02 Million USD | -5565.291% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -181454.076% |
| vTv Therapeutics Inc. | 529 Thousand USD | -32328.166% |
| Bio-Techne Corporation | 419.53 Million USD | 59.111% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -138.27% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 11.376% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -915.78% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -653.646% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -2731.71% |
| Nkarta, Inc. | 88.33 Million USD | -94.189% |
| BioCardia, Inc. | 1.31 Million USD | -12945.247% |
| Iterum Therapeutics plc | 19.5 Million USD | -779.312% |